Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Translational Phase 1B, 2-Part Study to Evaluate Pharmacokinetics, Safety and Pharmacodynamics of Treatment with ATX-304 Na Salt Tablets.

Next Previous
Trial Profile

A Translational Phase 1B, 2-Part Study to Evaluate Pharmacokinetics, Safety and Pharmacodynamics of Treatment with ATX-304 Na Salt Tablets.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 04 Sep 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ATX 304 (Primary)
  • Indications Cardiovascular disorders; Metabolic disorders; Obesity; Prediabetic state
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Amplifier Therapeutics; Betagenon

Most Recent Events

  • 26 May 2025 Status changed from recruiting to completed.
  • 17 Oct 2023 According to Amplifier Therapeutics, the trial is being conducted in the European Union.
  • 17 Oct 2023 Status changed from planning to recruiting as per Amplifier Media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top